Albumin antioxidant capacity is modified by methylglyoxal

Diabetes Metab. 2005 Apr;31(2):169-77. doi: 10.1016/s1262-3636(07)70183-0.

Abstract

Objective: Oxidative stress seems to play a major role in diabetic vascular complication development. Plasma albumin, via its thiol groups, is the main extracellular antioxidant molecule. Methylglyoxal (MG) is a very reactive dicarbonyl compound increased in diabetes which strongly modifies proteins by non-enzymatic glycosylation. The aim of this work was to study if MG could modify albumin antioxidant capacity.

Methods: Bovine serum albumin was incubated with 1 mM MG at 37 degrees C for 7 days (MG-BSA). Albumin physico-chemical changes were evaluated by tryptophan autofluorescence measurement in the presence or in the absence of a quencher (acrylamide). Albumin antioxidant capacity was determined by thiol measurement using Ellman's reagent as well as in a cellular system (HeLa cells stressed by H2O2).

Results: MG-BSA exhibited important modifications as shown by conformational changes, decreased tryptophan autofluorescence (30%) and significant thiol loss (40%). MG-BSA led to important modifications resulting in oxidation and loss of albumin antioxidant capacity. MG-BSA modifications were close to the one observed in albumin isolated from diabetic patients.

Conclusion: Our results suggest that deleterious effects induced by carbonyl stress in diabetes could also originate from a loss of albumin antioxidant capacity by dicarbonyl compound attack. The biological consequences of these findings have now to be investigated.

MeSH terms

  • Animals
  • Antioxidants*
  • Cattle
  • Diabetes Mellitus / blood*
  • Humans
  • Pyruvaldehyde / pharmacology*
  • Reference Values
  • Serum Albumin / metabolism*
  • Serum Albumin, Bovine / drug effects*
  • Serum Albumin, Bovine / physiology*
  • Sulfhydryl Compounds / blood

Substances

  • Antioxidants
  • Serum Albumin
  • Sulfhydryl Compounds
  • Serum Albumin, Bovine
  • Pyruvaldehyde